Orlando Clinical Research Center

OCRC specializes in conducting Phase I-IV clinical trials as an independent research site. It has extensive experience with first-in-human, pharmacokinetic/pharmacodynamic, bioavailability/bioequivalence, renal/hepatic impairment studies, and other early to late phase research. The facility supports both healthy volunteer and patient-based studies.

As a service provider/CRO site rather than a product company, it does not have its own drug pipeline or proprietary clinical results.

The center features advanced infrastructure including over 90–100 volunteer beds and specialized equipment for intensive monitoring.

It serves pharmaceutical and biotech companies developing new therapies.

All study-related care for participants is provided at no cost; compensation may be offered to volunteers.

The company emphasizes rapid study start-up times and thorough documentation processes.

No evidence of acquisition or closure was found; the company remains active as of June 2025.